Skip to main content

Table 7 Results of dose calculations for all patients

From: A 4D-CBCT correction network based on contrastive learning for dose calculation in lung cancer

RPD (%)

Dataset

Lung_L(V5Gy) (%)

Lung_R(V5Gy) (%)

Lung_L(V20Gy) (%)

Lung_R(V20Gy) (%)

PTV(D98%) (%)

PTV(D2%) (%)

P_spine(D2%) (%)

Patient01

4D-CBCT

1.0

11.5

1.4

0.0

2.9

3.5

3.9

4D-sCT(Cyc)

0.6

5.1

0.0

0.0

0.3

0.0

0.2

4D-sCT(CLC)

0.1

3.2

0.3

0.0

0.4

0.5

0.2

Patient02

4D-CBCT

22.2

5.4

0.0

0.7

0.7

5.2

6.6

4D-sCT(Cyc)

13.5

2.7

0.0

1.8

1.4

0.3

2.1

4D-sCT(CLC)

6.8

1.6

0.0

0.9

0.8

0.2

0.8

Patient03

4D-CBCT

0.3

0.4

0.7

0.4

0.1

0.8

1.0

4D-sCT(Cyc)

1.7

0.1

0.7

0.5

0.9

0.1

0.0

4D-sCT(CLC)

2.5

0.3

1.5

0.6

1.1

0.1

0.0

Patient04

4D-CBCT

18.0

2.0

0.0

4.2

1.9

4.2

0.5

4D-sCT(Cyc)

2.0

0.1

0.0

0.4

0.8

0.9

0.0

4D-sCT(CLC)

2.8

0.4

0.0

1.1

0.1

1.6

0.0

Patient05

4D-CBCT

5.2

9.1

3.3

6.3

1.7

3.5

6.3

4D-sCT(Cyc)

0.1

2.7

0.6

1.7

0.4

0.2

0.8

4D-sCT(CLC)

0.3

3.7

0.4

1.7

0.6

0.1

0.7

  1. RPD for five patients, based on the reference 4D-CT, were calculated for 4D-CBCT, sCT (Cyc), and sCT (CLC)